PuSH - Publikationsserver des Helmholtz Zentrums München

Bohn, B.* ; Bramlage, P.* ; Wagner, C.* ; Kaltheuner, M.* ; Welp, R.* ; Sziegoleit, S.* ; Zimmermann, A.* ; Reuter, H.M.* ; Hummel, M. ; Gloyer, J.* ; Holl, R.W.* ; Danne, T.*

Welche Patienten aus der Routinebetreuung verwenden das neue Insulin-Analogon Glargin U300 im Vergleich zu Patienten mit Glargin U100? Eine multizentrische Analyse von 14.123 Patienten mit Insulin Glargin aus den Diabetesregistern DPV und DIVE.  

Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100: A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE.

Wien. Med. Wochenschr. 168, 415–422 (2018)
DOI PMC
Summary: Background: Glargine U300 (Gla-300) is a further development of glargine U100 (Gla-100). Since 2015, Gla-300 has been available in Germany and Austria. We compared patients initiating therapy with Gla-300 with patients starting with Gla-100. Moreover, it was investigated whether patients from real-life diabetes care differ from patients participating in the EDITION clinical study program. Summary: Methods: Data are based on the diabetes registries DPV and DIVE. Patients started/switched to Gla-100 or Gla-300 in 2015 were included. Linear regression was applied for bodyweight (BW), BMI, HbA 1C , daily total and basal insulin dose/kgBW and negative binomial regression for severe hypoglycemia. Data were adjusted for age, sex, and diabetes duration. Summary: Results: 14,123 patients were identified (Gla-100: 11,397; Gla-300: 2726). Gla-300 patients with T1D were older, T2D patients younger compared to subjects using Gla-100 (both p < 0.0001). In Gla-300 subjects, diabetes duration was longer (both p < 0.0001). Patients started/switched to Gla-300 had a higher BW, a higher BMI and a lower baseline HbA 1C . The rate of severe hypoglycemia was comparable. Total and basal insulin doses/kgBW were higher in patients with Gla-300. Summary: DPV/DIVE subjects were older, had a lower BW, and were more frequently male compared to EDITION patients. HbA 1C was higher in T1D patients from DPV/DIVE. Summary: Conclusion: Data from the diabetes registries DPV/DIVE indicate differences between Gla-300 and Gla-100 patients at the onset of insulin therapy. This analysis provides additional information to the EDITION clinical study program.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Diabetes Registries ; Glargine U300 ; Routine Care ; Type 1 Diabetes ; Type 2 Diabetes
ISSN (print) / ISBN 0724-7176
Zeitschrift Wiener medizinische Wochenschrift
Quellenangaben Band: 168, Heft: 15-16, Seiten: 415–422 Artikelnummer: , Supplement: ,
Verlag Lehmann
Verlagsort München
Nichtpatentliteratur Publikationen
Institut(e) Institute of Diabetes Research Type 1 (IDF)